Labcorp Holdings Inc. (LH)
Labcorp's New Alliance With Graves Gilbert Clinic Set to Boost Stock
LH announces strategic agreement with Graves Gilbert Clinic for lab operations.
Labcorp Launches H5 Bird Flu Test Amid US Outbreak: Stock to Gain?
LH's new H5 bird flu test, developed in collaboration with the CDC, is now available in the United States.
LH Stock May Gain From Select MAWD Pathology Asset Purchase Deal
Labcorp is set to acquire select assets of MAWD Pathology Group.
Be Patient, Earn Dividends From Labcorp, The Leading Patient Clinical Lab Brand
For my initial coverage of Labcorp, I'm calling it a hold, and an opportunity to earn a $0.72/share quarterly dividend on the leading clinical lab company in the US. The firm shows future growth indicators through the growth of new locations and acquisitions, but also expected future patient demand for diagnostics. The company's main competitor/peer in this niche is Quest Diagnostics, and Labcorp struggles with a weak profit margin and growth in expenses.
Cinven secures Italian nod to sell minority stake in Synlab to Labcorp
Private equity firm Cinven secured a conditional approval from Italian authorities over its plan to sell a 15% stake in diagnostic service provider Synlab to laboratory operator Labcorp , a government document sent to parliament showed.
Is Labcorp Stock a Good Pick for Your Portfolio Right Now?
Investors are increasingly optimistic about LH due to its partnerships and operational discipline.
Labcorp Holdings Inc. (LH) Q3 2024 Earnings Call Transcript
Labcorp Holdings Inc. (NYSE:LH ) Q3 2024 Earnings Conference Call October 24, 2024 9:00 AM ET Company Participants Christin O'Donnell – Vice President-Investor Relations Adam Schechter – Chairman and Chief Executive Officer Glenn Eisenberg – Executive Vice President and Chief Financial Officer Conference Call Participants Ann Hynes – Mizuho Lisa Gill – JPMorgan Michael Cherny – Leerink Partners Patrick Donnelly – Citi Erin Wright – Morgan Stanley David Westenberg – Piper Sandler Jack Meehan – Nephron Research Pito Chickering – Deutsche Bank Andrew Brackmann – William Blair Kevin Caliendo – UBS Elizabeth Anderson – Evercore ISI Eric Coldwell – Baird Stephanie Davis – Barclays John Kim – Bank of America Operator Good day and thank you for standing by. Welcome to the Q3 2024 Labcorp Holdings Earnings Conference Call.
LH Beats on Q3 Earnings, Raises Revenue Guidance Midpoint, Stock Gains
Labcorp beats on earnings and revenues in the third quarter, entering the fourth half of 2024 with robust momentum.
Compared to Estimates, Labcorp (LH) Q3 Earnings: A Look at Key Metrics
The headline numbers for Labcorp (LH) give insight into how the company performed in the quarter ended September 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Laboratory Corp Q3 Earnings Beat Street View, Investors Overlook Hurricane Helene Impact
Thursday, Laboratory Corp LH reported third-quarter 2024 adjusted earnings per share of $3.50, up from $3.38 a year ago, beating the consensus of $3.49.
Labcorp (LH) Q3 Earnings and Revenues Surpass Estimates
Labcorp (LH) came out with quarterly earnings of $3.50 per share, beating the Zacks Consensus Estimate of $3.48 per share. This compares to earnings of $3.38 per share a year ago.
Labcorp beats quarterly estimates on diagnostic test demand
Laboratory operator Labcorp on Thursday beat Wall Street estimates for third-quarter profit and revenue, helped by demand for diagnostic tests.
